Isterian Biotech
PrivateCompany Overview
Isterian Biotech is a biotechnology company that is a developer of therapeutics drugs designed for the treatment of fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
TG2 inhibitorIdiopathic Pulmonary FibrosisIPFsmall molecule drugsfibrotic disease therapypreclinical biotechdrug discoveryinhaled therapyfirst-in-class therapypipeline companylongevity biotechcomputer-aided drug designCADDgerosciencepipecopharma licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isterian Biotech Comparables
Compare Isterian Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rein Therapeutics | 78% | |
| Avalyn Pharma | 73% | |
| Pliant Therapeutics | 73% | |
Isterian Biotech Funding Rounds
Historical fundraising activity
Isterian Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Isterian Biotech's valuation, stock price, and market status.
See something wrong or outdated?